US_FEDERAL process · buyer country US · award
PURCHASE ANTI-ANTHRAX TOXIN ANTIBODY, RAXIBACUMAB, IN A SINGLE GLASS VIAL AT THE CONCENTRATION OF 10 MG/ML.
Department of Health and Human Services
Not reported
Data last updated Oct 22, 2026 · Source: USAspending.gov
- Buyer identifier
- Not reported
- Primary supplier
- LIFE TECHNOLOGIES CORPORATION
- Procurement method
- Not reported
- Tender deadline
- Not reported
- Contract period
- Not reported — Not reported
- Native value
- Not reported
- USD comparison
- Not shown — no auditable FX observation
- Official source
- Open notice ↗
Description
PURCHASE ANTI-ANTHRAX TOXIN ANTIBODY, RAXIBACUMAB, IN A SINGLE GLASS VIAL AT THE CONCENTRATION OF 10 MG/ML.
Suppliers
- LIFE TECHNOLOGIES CORPORATION · primary
Official lifecycle
Process timeline
- Award announced
PURCHASE ANTI-ANTHRAX TOXIN ANTIBODY, RAXIBACUMAB, IN A SINGLE GLASS VIAL AT THE CONCENTRATION OF 10 MG/ML.
- Value increased
PURCHASE ANTI-ANTHRAX TOXIN ANTIBODY, RAXIBACUMAB, IN A SINGLE GLASS VIAL AT THE CONCENTRATION OF 10 MG/ML.
Auditable model output
Predictive intelligence
Append-only source history
Source records
| Record | Date | Stages | Fetched |
|---|